Literature DB >> 9363968

Postlicensure effectiveness of varicella vaccine during an outbreak in a child care center.

H S Izurieta1, P M Strebel, P A Blake.   

Abstract

CONTEXT: Because lyophilized varicella vaccine must be stored frozen at -15 degrees C or less (> or = 5 degrees F) and administered within 30 minutes after reconstitution, the potential exists for decreased vaccine effectiveness when the vaccine is used under field conditions.
OBJECTIVES: To describe an outbreak of varicella in a child care center and to determine postlicensure effectiveness of varicella vaccine.
DESIGN: Retrospective cohort study.
SETTING: A child care center in DeKalb County, Georgia, in 1996. PARTICIPANTS: Of the 184 children registered in the child care center, 148 were eligible for the study based on absence of history of varicella before January 1, 1996. MAIN OUTCOME MEASURES: Data on disease status, severity and impact of disease, and risk factors for varicella and for vaccine failure were obtained from parents and their children's pediatricians. Varicella vaccine effectiveness was calculated among children aged 12 months or older (eligible for vaccination) using the cohort method.
RESULTS: The outbreak started on January 17, 1996, and lasted 15 weeks. Of the 148 eligible children, 81 (55%) developed varicella. Cases among children younger than 12 months (n =7) were more severe than cases among older children. Varicella occurred in 9 (14%) of 66 vaccinated children and 72 (88%) of 82 unvaccinated children. Varicella was less severe and resulted in fewer days of absence from the child care center among vaccinated compared with unvaccinated cases. Varicella vaccine effectiveness against all forms of disease was 86% (95% confidence interval [CI], 73%-92%), and against moderate-to-severe varicella disease it was 100% (95% CI, 96%-100%). Vaccinated children with asthma or other reactive airway diseases were 7.1 times more likely to have varicella than were vaccinated children without reactive airway diseases (95% CI, 2.4-21.3).
CONCLUSIONS: Varicella vaccine administered under routine conditions in physicians' offices was highly effective in preventing varicella in an outbreak characterized by intense exposure. The role of asthma and other reactive airway diseases as risk factors for varicella disease and vaccine failure deserves to be investigated further.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9363968

Source DB:  PubMed          Journal:  JAMA        ISSN: 0098-7484            Impact factor:   56.272


  30 in total

1.  Attitudes and practices regarding varicella vaccination among physicians in Minnesota: implications for public health and provider education.

Authors:  K R Ehresmann; W A Mills; P R Loewenson; K A Moore
Journal:  Am J Public Health       Date:  2000-12       Impact factor: 9.308

2.  Varicella vaccination in England and Wales: cost-utility analysis.

Authors:  M Brisson; W J Edmunds
Journal:  Arch Dis Child       Date:  2003-10       Impact factor: 3.791

3.  A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China.

Authors:  Li Lu; Luodan Suo; Juan Li; Lijun Zhai; Qingxiu Zheng; Xinghuo Pang; Stephanie R Bialek; Chengbin Wang
Journal:  Vaccine       Date:  2012-06-09       Impact factor: 3.641

Review 4.  Aciclovir and varicella-zoster-immunoglobulin in solid-organ transplant recipients.

Authors:  Martina Prelog; Jörn Schönlaub; Lothar Bernd Zimmerhackl
Journal:  Pediatr Nephrol       Date:  2010-11-15       Impact factor: 3.714

Review 5.  Economic evaluations of varicella vaccination programmes: a review of the literature.

Authors:  Nancy Thiry; Philippe Beutels; Pierre Van Damme; Eddy Van Doorslaer
Journal:  Pharmacoeconomics       Date:  2003       Impact factor: 4.981

6.  Towards universal childhood immunization against chickenpox?

Authors:  B J Law
Journal:  Paediatr Child Health       Date:  2000-07       Impact factor: 2.253

7.  Effectiveness of vaccination against varicella in children under 5 years in Puglia, Italy 2006-2012.

Authors:  Silvio Tafuri; Francesca Fortunato; Maria Giovanna Cappelli; Vanessa Cozza; Angela Bechini; Paolo Bonanni; Domenico Martinelli; Rosa Prato
Journal:  Hum Vaccin Immunother       Date:  2014-11-01       Impact factor: 3.452

8.  Varicella vaccination in Italy : an economic evaluation of different scenarios.

Authors:  Laurent Coudeville; Alain Brunot; Carlo Giaquinto; Carlo Lucioni; Benoit Dervaux
Journal:  Pharmacoeconomics       Date:  2004       Impact factor: 4.981

9.  Three-year follow-up of protection rates in children given varicella vaccine.

Authors:  David W Scheifele; Scott A Halperin; Francisco Diaz-Mitoma
Journal:  Can J Infect Dis       Date:  2002-11

10.  Genome-wide mutagenesis reveals that ORF7 is a novel VZV skin-tropic factor.

Authors:  Zhen Zhang; Anca Selariu; Charles Warden; Grace Huang; Ying Huang; Oluleke Zaccheus; Tong Cheng; Ningshao Xia; Hua Zhu
Journal:  PLoS Pathog       Date:  2010-07-01       Impact factor: 6.823

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.